SABBY CLRB 13G 08.20.14

Company

Cellectar Biosciences, Inc.

Filed

August 20, 2014

Accession Number

0001535610-14-000068

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →